Carles Monterrubio

Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8

Carles Monterrubio, Sonia Paco, Nagore G. Olaciregui et al. · Journal of Controlled Release · 2017 · 46 citations · Full text

Nanoparticles, Nanomedicine, Drug Targeting +11

SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery

Carles Monterrubio, Guillem Pascual‐Pasto, Francisco Cano et al. · Biomaterials · 2015 · 43 citations · Full text

Tissue Engineering, Nanoparticles, Engineering +12

Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

Guillem Pascual‐Pasto, Nagore G. Olaciregui, Mònica Vilà-Ubach et al. · Cancer Letters · 2016 · 31 citations · Full text

Tumor Biology, Xenotransplantation, Molecular Markers +10

Coamplification of <i>miR-4728</i> protects <i>HER2</i> -amplified breast cancers from targeted therapy

Konstantinos V. Floros, Timothy L. Lochmann, Bin Hu et al. · Proceedings of the National Academy of Sciences · 2018 · 30 citations · Full text

Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas

Alexandra Bukchin, Guillem Pascual‐Pasto, Maria Cuadrado‐Vilanova et al. · Journal of Controlled Release · 2018 · 28 citations

Nanomedicine, Engineering, Glycobiology +4